Navigation Links
Event in Medical Technology

R-Tech Ueno, Ltd. Completes Phase 1 Clinical Study on RK-023

... repeated-dose study. Since no serious adverse event occurred in each test, RK-023 seems to hardly ... followed by UVA irradiation No adverse event occurred and the resulting irritation was ... in the entire body and scalp. No serious adverse event occurred. After application of the drug, blood ...

Ironwood and Forest Present Additional Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation

... serious adverse events. The most common adverse event was diarrhea; however, there were no associated ... Across both studies, the most common adverse event in the linaclotide-treated groups was diarrhea, and diarrhea was the most common adverse event leading to discontinuation. Linaclotide is a once ...

Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF Presented at American Thoracic Society (ATS)

... in FVC (p=0.001) when compared to placebo. A PFS event was defined in the study protocol as the time to ... discontinuing treatment due to an adverse event across both studies combined was 15% and 9% in ... of patients who experienced a serious adverse event (SAE). An SAE was reported by 35% and 33% of ...

Juvenile Diabetes Research Foundation to Honor Duane DeSisto of Insulet Corporation and Senator Edward M. Kennedy at 27th Annual Hearts & Heroes Gala

... to U.S. Senator Edward M. Kennedy. The black tie event is expected to raise $1.5 million for research to ... they became a Bronze Research Sponsor of the Main event Gala. Insulet has continued to support and ... Maria Stephanos and Mark Ockerbloom will serve as event emcees. About JDRF JDRF is the leader ...

BIOCOM's 4th Annual DeviceFest Honors Companies

... ALL DAY event SHOWCASED MEDICAL DEVICE INNOVATIONS AND SOUTHERN ... latest in medical device technology. The all-day event at the Fairmont Hotel was sponsored by BIOCOM, ... for their innovations. Key sponsors of the event included: Mentus Life Science , Continuum , ...

BioCryst Provides Peramivir Update and Reports First Quarter 2009 Financial Results

... thousand patients and will be delivered in the event that the government so instructs. Intravenous ... of providing peramivir through an EUA in the event of a severe influenza outbreak with significant ... safe and well tolerated with a similar adverse event profile noted in the peramivir and placebo ...

Poniard Pharmaceuticals to Present New Data from Phase 2 Clinical Trials of Picoplatin in Multiple Tumor Types at the 45th Annual Meeting of the American Society of Clinical Oncology

... Prostate Trials - - Company to Hold Investor event on Sunday, May 31 with Oncology Experts - ... Level 2, West Hall E1 Poniard Investor event In addition to the picoplatin posters and ... begin promptly at 6:00 p.m. Eastern Time. The event will feature presentations and discussion with ...

USAID Cooperates in Pandemic Preparedness Initiative

... capacity to thwart a humanitarian disaster in the event of a pandemic. As recently emphasized by ... humanitarian response to such needs in the event of a pandemic. With this week's exercise, ... that will continue to affect people in the event of a pandemic. This will help reduce excess ...

Study Data Show Positive European Experience With DuraHeart Left Ventricular Assist Device for Advanced Stage Heart Failure Patients

... improved survival rate and an acceptable adverse event rate in advanced heart failure patients who were ... renal dysfunction. The total major adverse event rates during DuraHeart support were acceptable in ... and second generation axial flow LVADs. The event rate of bleeding requiring surgery (0.22 per ...

Anti-Aging Expo & Symposium Showcases in Charlotte on March 28th

... is this year's premier health and wellness event in the queen city. With expert speakers and over ... product demonstrations and plenty of prizes, this event is intended to shift your thinking about your health. The one day event is on Saturday, March 28th, 2009, at the ...

Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C

... patients who had a serious and/or severe adverse event or discontinued due to an adverse event was comparable in all dose groups: 23.2% ... U.S. Strategic National Stockpile for use in the event of an emergency for the treatment of inhalation ...

Diabetes Patients with High Triglycerides and Low HDL Cholesterol Get the Most Benefit From Fenofibrate Treatment: New Data From the FIELD Study

... to new data from the Fenofibrate Intervention and event Lowering in Diabetes (FIELD) study published in ... can prevent one fatal or non-fatal cardiovascular event by treating only 23 of these patients over ... was 23 patients needing to be treated for one event to be prevented. By comparison, the ...

Third Pivotal Phase 3 Study for NicOx' Naproxcinod Shows Positive Efficacy, Safety and Blood Pressure Results

... bid showed the same gastrointestinal (GI) adverse event rate and a similar blood pressure profile to ... of patients who experienced at least one adverse event overall, this was lower for naproxcinod 750 ... serious cardiovascular or serious GI adverse event in the naproxcinod arm during the 13 weeks of ...

Tackling Atrial Fibrillation and Associated Cardiovascular Risk

... email containing instructions on how to join the event (event number and password) on the day of the ... pop-up window Please ensure you log on to the event 15 minutes before the start time so as not to miss valuable information. IMPORTANT NOTICE: This event is not part of the official Scientific Sessions ...

Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R)

... or CNS adverse events (10.3% vs. 23.3%). GI event severity was also subjectively lowered with the ... populations; the discontinuation due to adverse event rates associated with them ranged from 13.8% to ... rate of early discontinuation due to any adverse event (13.8% versus 16.0%). -- Across the Contrave ...

Five-Year Data Confirm That Early Treatment with Betaseron(R) at First Sign of Disease Can Delay Progression to MS

... beta-1b) treatment in patients with a first event suggestive of multiple sclerosis (MS) ... that treatment with Betaseron after the first MS event or attack can reduce the risk of developing MS ... -- Starting Betaseron after the first clinical event delayed the development of CDMS by more than two ...

Olanzapine Long-Acting Injection (LAI) Shown to Maintain Treatment Benefit in Schizophrenia for up to Six Months

... trials through 30 September 2007; adverse event data through 31 May 2008 were also reviewed. As ... rate of 1.4 per cent - or approximately one event per 1,400 injections. No clinically significant ... an Olanzapine LAI Post-Injection Syndrome event after one year of treatment was 0.7 to ...

Cardica to Host Investor Briefing on 'Revolutionizing Revascularization'

... - event to Be Webcast June 12 at 5:15 p.m. Eastern Time ... June 12, at 5:15 p.m. Eastern Time in Boston. The event will feature a panel of renowned cardiovascular ... PAS-Port system. Panelists for the investor event will include: -- Husam H. Balkhy, M.D., ...

Chasing Zero Summit Pushes for Zero Tolerance Approach to Hospital-Acquired Infections

... host the inaugural Chasing Zero Summit. The event will focus on the leadership and operational ... for a zero-tolerance approach for HAIs. The event features an intimate, in-depth and ... HAI reimbursement changes from CMS. Who The event will bring health care industry leaders together ...

New Data Offers Insights Into the Potential Role for TYKERB(R) (Lapatinib) in Non-Cytotoxic Chemotherapy-Based Treatment Regimens

... progression, patients withdrew due to an adverse event (AE) or withdrawal of consent.(1) Three patients ... hemorrhage and one Grade 3 hypertensive event were reported.(2) "In this study, blocking the ... TYKERB. Diarrhea was the most common adverse event resulting in discontinuation of study medication. ...

New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients

... will attend the meeting which is the premier event for cancer therapy worldwide. The Roche data ... on Friday 30th May at an invitation-only media event for non-US journalists. All abstracts are ... are interested in attending the Roche Media event during ASCO on 30th May, where the data outlined ...

New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting

... the primary assessment was time to a depressed event using criteria including the MADRS. Doses of 50 ... (n=23) a lower dose. The risk of a depressed event was significantly reduced for SEROQUEL XR compared with placebo suggesting increased time to event (HR = 0.34 [0.25, 0.46]; p (34.4%) ...

Colorado Cancer Research Program Will Host Golf Event to 'Drive' the Message that Clinical Trials Play a Vital Role in the Quest to Find a Cure for Cancer

... that I am proud to sponsor." The cost of the event is $185 per player. Golfers without a ... lunch and dinner. Registration for this year's event begins at 11:30 am. This event has a best ball scramble format and will kick off ...

U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older

... section states that the post-marketing adverse event profile that was observed in adult RA patients ... should be available for immediate use in the event of a reaction. Infections: Caution should be ... treated with ORENCIA developed a serious adverse event compared to those on placebo (27 percent vs. ...

Microbia and Forest Laboratories Announce Preliminary Results of Linaclotide Phase 2b Studies

... the treatment period. The most common adverse event was diarrhea, which was dose-related and ranged ... at all doses; there was one serious adverse event in a linaclotide-treated patient which was ... by the investigator. The most common adverse event was diarrhea, and diarrhea was the most common ...

NicOx' Naproxcinod Phase 3 Results Presented at American College of Rheumatology

... the gastro-intestinal adverse event rates and blood pressure measurements reported ... of patients experiencing at least one adverse event at 750 mg and 375 mg bid, respectively. In the ... mg and 375 mg bid treatment groups reported event rates of 17.0% and 12.9%, respectively and the ...

Artists for a New South Africa Will be 'Shaking The Blues' at Gala Benefit November 15, With Performances by Erykah Badu, Nikka Costa, Keb' Mo', Taj Mahal Trio, The Roots, and Guest Stars at The Wiltern in Los Angeles

... event CHAIRS INCLUDE JACKSON BROWNE, MORGAN FREEMAN, ... global -- and make a difference in the world. The event will feature blues-influenced musical artists as ... fight against HIV/AIDS in the US and Africa. The event begins with a pre-show cocktail party for major ...

Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression

... beta-1b) shortly after their first clinical MS event or "attack" showed a 40 percent lower risk of ... initiated after a first clinical event with delayed treatment. The study was conducted ... with Betaseron shortly after the first clinical event suggestive of MS can delay disability ....

Meta-Analysis of Clinical Data Showed No Increased Risk of Cardiovascular Events Associated With Exenatide Use: Data Presented at ADA 2009

... weeks, the unadjusted rate at which patients experienced at least one CV event was 2.0 percent for BYETTA and 2.6 percent for the comparator group; the ... respectively. The unadjusted incidence of experiencing at least one CV event was 2.0 percent for BYETTA and 2.6 percent for pooled comparator; the ...

Research: Popular Diabetes Medications Associated with Increase in Bone Fractures

... experienced a 44 percent higher relative risk for a cardiovascular event than patients taking clopidogrel alone. Of those who took the medications together, nearly 27 percent experienced a major cardiovascular event within the first 12 months of taking the drugs together, compared to only ...

Horizon Therapeutics' HZT-501 Significantly Reduces Incidence of NSAID-Induced Upper Gastrointestinal Ulcers in Patients With Mild-to-Moderate Pain

... to moderate in severity. There were no significant differences in adverse event or serious adverse event profiles between the two treatment groups. One death occurred in the ...

New Preliminary Data from Two Studies Show Clinical Activity of Neratinib in Combination with Trastuzumab and in Combination with Paclitaxel in Advanced HER-2 Positive Breast Cancer

... CI, 55.9 percent to 69.4). In this preliminary analysis, the adverse event profile of the combination of neratinib (240 mg) plus paclitaxel (80 ... anemia, nausea, rash, fatigue and vomiting. The most common adverse event was diarrhea, observed in 89 percent of the 102 patients enrolled in part ...

Poniard Pharmaceuticals Announces Progression-Free Survival Data From Phase 2 Clinical Trial of Picoplatin in Metastatic Colorectal Cancer

... Analyst and Investor Briefing Poniard will host an investor event in Orlando on Sunday, May 31, 2009. Presentations will begin promptly at 6:00 p.m. Eastern Time. The event will feature presentations and discussion with expert oncologists, ...

RAPAFLO(TM) (silodosin) Provides Rapid and Sustained Benign Prostatic Hyperplasia (BPH) Symptom Relief in as Little as Three Days

... through 12 weeks of treatment. The most common drug-related adverse event (AE) was retrograde ejaculation (orgasm with reduced semen), an expected ... was retrograde ejaculation. The second most commonly-reported adverse event was dizziness. The incidence of treatment-related dizziness was low and ...

New Studies Show Popular Heartburn Medications Moderate the Effect of Taking Widely Prescribed Heart Drug

... with clopidogrel increases the risk of hospitalization for a CV event by 51 percent, and that individual PPIs each significantly raise that risk ... a stent procedure but were not taking clopidogrel and compared CV event hospitalizations of patients on a PPI to those not taking a PPI. These ...

Two-Year Phase III Data Presented at AAN 61st Annual Meeting Show Positive Outcome of Cladribine Tablets in Patients With Multiple Sclerosis

... upper respiratory tract infections and nausea. Lymphopenia, an expected event based on the presumed mechanism of action of cladribine, occurred more ... at risk of developing MS (patients who have experienced a first clinical event suggestive of MS). This trial was announced in September 2008. - The ...

Oakwood Surgeons Perform World's First 3D Surgery Without Special Glasses

... technologies developed by Absolute Imaging, LLC, of Livonia, MI. This event marks the first time in history that a surgeon looked at a display and ... Heritage Hospital and one of the key orchestrators of this historic event is optimistic about the future of this technology. According to Smith, ...

Schering-Plough's Investigational Oral Thrombin Receptor Antagonist Meets Primary Endpoint in a Newly Published Study

... statistically significant, the incidence of death or major adverse cardiac event (MACE) at 60 days was 9 percent in the placebo group compared to 6 percent ... Study Group. The Phase III Thrombin Receptor Antagonist Clinical event Reduction in acute coronary syndrome (TRA-CER) trial is a multinational, ...

New Research Suggests Platelet 'Stickiness' May be the Single Most Important Risk Factor in Patients Treated with Coronary Stents - Findings May be Applicable to Anyone with Vascular Disease

... the cholesterol level in everyone with vascular disease, yet the pivotal event that kills the patient - platelet aggregation isn't being assessed in any ... high cholesterol and plaque-filled arteries may never have a cardiac event because they had low platelet aggregation. Along with his team at ...

Research Highlights New Approaches to Prevent Blood Clots in Several High-Risk Patient Populations Including Largest Study Ever to Examine Use of Blood-Thinning Medication in Patients With Cancer

... Only 16 of the 769 patients treated with nadroparin had a thromboembolic event (2.1 percent) compared with 15 of the 381 patients (3.9 percent) in the ... group, a 47.2 percent reduction in the risk of developing a thromboembolic event for the patients in the treatment arm. The drug also appeared to be safe ...
Other Contents
(Date:12/10/2014)... , Dec. 9, 2014  Wake Forest Baptist Medical ... building for its School of Medicine. Funding for this ... capital campaign that will be publicly launched next summer. ... located in the former 60 series R.J. Reynolds Tobacco ... Quarter. Construction will begin immediately with plans to be ...
(Date:12/5/2014)...  Tute Genomics, a leader in cloud-based solutions for ... funding led by UK-based Eurovestech. Peak Ventures and a ... round. "We are at a pivotal time ... and seeks new approaches for the diagnosis, treatment and ... MBA, and CEO of Tute Genomics. "One of the ...
(Date:11/21/2014)... YORK , Nov. 19, 2014  Earlier this ... at New York College, and one of the most ... biosensor signals that are transmitted from Smartphones to third ... were Smartphones and has one of the earliest known ... discussing its usage in the military, child care, elder ...
Breaking Biology News(10 mins):Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 2Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 2Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 4
(Date:12/22/2014)... NY (PRWEB) December 22, 2014 ... a federal panel of judges has granted a request ... in the U.S. District Court, Eastern District of Louisiana. ... an order on December 12 to transfer over 50 ... 22 districts to the Louisiana court for consolidation under ...
(Date:12/22/2014)... FL (PRWEB) December 22, 2014 Christmas is ... Beauty® has a fast and easy solution that will please: ... cards can be purchased from from $25 up to $350," ... offer 100% customer satisfaction and a wide array of skin ... no fees and no expiration dates. , Gift delivery ...
(Date:12/22/2014)... 22, 2014 The NLN’s ... development programs this month. Faculty have been selected ... nurse educators fast-tracked for administrative leadership roles within ... Program for Simulation Educators, featuring a curriculum uniquely ... nursing education. , Twenty nurse educators were ...
(Date:12/21/2014)... (PRWEB) December 22, 2014 Recently, BambooFlooringChina.com, ... durable strand woven bamboo flooring collection , and launched ... 25%. The promotion is valid until Jan. 30, 2015. ... woven bamboo is the hardest bamboo flooring available today; ... resembling that of traditional teak hardwoods. Strand woven bamboo ...
(Date:12/21/2014)... 21, 2014 When families in Coral Gables ... they call? The new answer is Lice Troopers . ... 33134, their newest treatment center will be the new go-to ... and without the use of harmful chemicals or pesticides. ... January 1, 2015. Like the company’s first clinic (located at ...
Breaking Medicine News(10 mins):Health News:Panel Orders Xarelto Lawsuits Consolidated Into Multi-District Litigation Reports Alonso Krangle LLP 2Health News:Panel Orders Xarelto Lawsuits Consolidated Into Multi-District Litigation Reports Alonso Krangle LLP 3Health News:Panel Orders Xarelto Lawsuits Consolidated Into Multi-District Litigation Reports Alonso Krangle LLP 4Health News:NLN Leadership Institute Announces 2015 Cohorts 2Health News:NLN Leadership Institute Announces 2015 Cohorts 3Health News:BambooFlooringChina.com Announced Its Durable Strand Woven Bamboo Flooring Collection 2Health News:All-Natural Florida Lice Removal Company Opens New Lice Treatment Salon In South Florida 2
Other TagsOther Tags